Revised SPC: Stelara (ustekinumab) pre-filled syringes

SPC highlights a licence extension for use in moderate to severe plaque psoriasis in children and adolescent patients from the age of 6 years and older, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.

Source:

electronic Medicines compendium